Page last updated: 2024-12-09

olanexidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

olanexidine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID636391
CHEMBL ID1190262
CHEBI ID134712
SCHEMBL ID374304
SCHEMBL ID16892975
MeSH IDM0293616

Synonyms (24)

Synonym
1-(3,4-dichlorobenzyl)-5-octylbiguanide
CHEBI:134712
olanexidine
1-[n'-[(3,4-dichlorophenyl)methyl]carbamimidoyl]-2-octylguanidine
146510-36-3
olanexidine [inn]
unii-92c2328g7p
imidodicarbonimidic diamide, n-((3,4-dichlorophenyl)methyl)-n'-octyl
92c2328g7p ,
imidodicarbonimidicdiamide, n-[(3,4-dichlorophenyl)methyl]-n'-octyl-
CHEMBL1190262
olanexidine [who-dd]
imidodicarbonimidic diamide, n-((3,4-dichlorophenyl)methyl)-n'-octyl-
olanexidine [mi]
SCHEMBL374304
ZZQMUJGZCZTLQD-UHFFFAOYSA-N
SCHEMBL16892975
Q21099133
NCGC00538147-01
n1-(3,4-dichlorobenzyl)-n5-octylbiguanide
imidodicarbonimidic diamide, n-[(3,4-dichlorophenyl)methyl]-n'-octyl-
DTXSID601318290
CS-0092621
HY-125654

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
dichlorobenzeneAny member of the class of chlorobenzenes carrying two chloro groups at unspecified positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (17.65)18.2507
2000's4 (23.53)29.6817
2010's4 (23.53)24.3611
2020's6 (35.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.04 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index5.37 (4.65)
Search Engine Demand Index33.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (17.65%)5.53%
Reviews1 (5.88%)6.00%
Case Studies1 (5.88%)4.05%
Observational0 (0.00%)0.25%
Other12 (70.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]